Advertisement

Topics

Eleven Biotherapeutics to Present at Upcoming Investor Conferences in March

08:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing a broad pipeline of novel product candidates based on its Targeting Protein Therapeutics (TPTs) platform, today announced that Stephen ...

Other Sources for this Article

Stern Investor Relations
Hannah Deresiewicz
hannahd@sternir.com

NEXT ARTICLE

More From BioPortfolio on "Eleven Biotherapeutics to Present at Upcoming Investor Conferences in March"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...